日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

通过 IN-DEPTH 进行同一张载玻片空间多组学整合,揭示了肿瘤病毒相关的肿瘤微环境空间重组。

Yiu Stephanie Pei Tung, Chang Yuzhou, Yeo Yao Yu, Qiu Huaying, Wu Wenrui, Michel Hendrik A, Jin Xiaojie, Huang Rongting, Kure Shoko, Parmelee Lindsay, Luo Shuli, Cramer Precious, Lee Jia Le, Wang Yang, Zhao Zhangxin, Yeung Jason, El Ahmar Nourhan, Simsek Berkay, Mohanna Razan, Van Orden McKayla, Lu Wesley S, Livak Kenneth J, Li Shuqiang, Gao Ce, Burgess Melinda, Keane Colm, Shahryari Jahanbanoo, Kingsley Leandra G, Al-Humadi Reem N, Nasr Sahar, Nkosi Dingani, Sadigh Sam, Rock Philip, Frauenfeld Leonie, Kaufmann Louisa, Zhu Bokai, Basak Ankit, Dhanikonda Nagendra, Chan Chi Ngai, Krull Jordan, Cho Ye Won, Chen Chia-Yu, Brown Jonathan, Wang Hongbo, Zhao Bo, Lee Jia-Ying Joey, Loo Lit-Hsin, Kim David M, Boussiotis Vassiliki A, Zhang Baochun, Wei Kevin, Shalek Alex K, Howitt Brooke E, Signoretti Sabina, Schürch Christian M, Hodi F Stephen, Burack W Richard, Rodig Scott J, Ma Qin, Jiang Sizun

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

遗传性线粒体基因作为黑色素瘤免疫检查点抑制剂疗效的预测因子

Monson, Kelsey R; Ferguson, Robert; Handzlik, Joanna E; Morales, Leah; Xiong, Jiahan; Chat, Vylyny; Dagayev, Sasha; Khodadadi-Jamayran, Alireza; Simpson, Danny; Kazlow, Esther; Bunis, Anabelle; Sreenivasaiah, Chaitra; Ibrahim, Milad; Voloshyna, Iryna; Ouwerkerk, Wouter; Luiten, Rosalie M; Capone, Mariaelena; Madonna, Gabriele; Lu, Yuting; Shao, Yongzhao; Pavlick, Anna; Krogsgaard, Michelle; Mehnert, Janice; Tang, Hao; Dolfi, Sonia; Tenney, Daniel; Haanen, John B A G; Gajewski, Thomas F; Hodi, F Stephen; Flaherty, Keith T; Couts, Kasey; Robinson, William; Puzanov, Igor; Ernstoff, Marc S; Rahma, Osama; Postow, Michael; Sullivan, Ryan J; Luke, Jason J; Ascierto, Paolo A; Osman, Iman; Kirchhoff, Tomas

Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma

转移性黑色素瘤获得性免疫治疗耐药的基因组介质

Julia Schiantarelli,Mouadh Benamar,Jihye Park,Haley E Sax,Giacomo Oliveira,Alice Bosma-Moody,Katie M Campbell,David Liu,Douglas B Johnson,Scott Rodig,Catherine J Wu,F Stephen Hodi,Antoni Ribas,Eliezer Van Allen,Rizwan Haq

CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

CRATER肿瘤微环境促进CD8+ T细胞的激活,并与免疫治疗的成功相关。

Aya Ludin ,Georgia L Stirtz ,Asaf Tal ,Ajit J Nirmal ,Kathleen L Pfaff ,Michael Manos ,Naomi Besson ,Nebiyat Eskndir ,Billie Porter ,Stephanie M Jones ,Hannah M Faulkner ,Qiyu Gong ,Sophia Liu ,Irving Barrera ,Lijian Wu ,Cecilia Pessoa Rodrigues ,Aditi Sahu ,Elizabeth Jerison ,Joao V Alessi ,Biagio Ricciuti ,Douglas S Richardson ,Jodi D Weiss ,Hadley M Moreau ,Meredith E Stanhope ,Alexander B Afeyan ,James Sefton ,Wyatt D McCall ,Emily Formato ,Song Yang ,Yi Zhou ,David P Hoytema van Konijnenburg ,Hannah L Cole ,Miguel Cordova ,Liang Deng ,Milind Rajadhyaksha ,Stephen R Quake ,Mark M Awad ,Fei Chen ,Kai W Wucherpfennig ,Peter K Sorger ,F Stephen Hodi ,Scott J Rodig ,George F Murphy ,Leonard I Zon

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204

CheckMate 204 研究中接受纳武利尤单抗联合伊匹木单抗治疗的黑色素瘤脑转移患者的颅内反应评估标准比较分析

Huang, Raymond Y; Youssef, Gilbert; Nelson, Thomas; Wen, Patrick Y; Forsyth, Peter; Hodi, F Stephen; Margolin, Kim; Algazi, Alain P; Hamid, Omid; Lao, Christopher D; Ernstoff, Marc S; Moschos, Stergios J; Atkins, Michael B; Postow, Michael A; Reardon, David A; Grootendorst, Diederik J; Leung, David; Askelson, Margarita; Ritchings, Corey; Tawbi, Hussein A

Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047

RELATIVITY-047 研究显示,在晚期黑色素瘤患者中,使用纳武利尤单抗联合瑞拉利单抗治疗的三年总生存期为 3 年。

Tawbi, Hussein A; Hodi, F Stephen; Lipson, Evan J; Schadendorf, Dirk; Ascierto, Paolo A; Matamala, Luis; Castillo Gutiérrez, Erika; Rutkowski, Piotr; Gogas, Helen; Lao, Christopher D; Janoski De Menezes, Juliana; Dalle, Stéphane; Arance, Ana Maria; Grob, Jean-Jacques; Ratto, Barbara; Rodriguez, Saima; Mazzei, Antonella; Dolfi, Sonia; Long, Georgina V

Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data

更正:一线治疗晚期黑色素瘤:纳武利尤单抗联合瑞拉利单抗对比纳武利尤单抗联合伊匹木单抗:基于 RELATIVITY-047 和 CheckMate 067 试验数据的间接治疗比较

Long, Georgina V; Lipson, Evan J; Hodi, F Stephen; Ascierto, Paolo A; Larkin, James; Lao, Christopher; Grob, Jean-Jacques; Ejzykowicz, Flavia; Moshyk, Andriy; Garcia-Horton, Viviana; Zhou, Zheng-Yi; Xin, Yiqiao; Palaia, Jennell; McDonald, Laura; Keidel, Sarah; Salvatore, Anthony; Patel, Divya; Sakkal, Leon A; Tawbi, Hussein; Schadendorf, Dirk

Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma

纳武利尤单抗联合伊匹木单抗或单用纳武利尤单抗治疗晚期黑色素瘤患者的长期汇总结果

Long, Georgina V; Larkin, James; Schadendorf, Dirk; Grob, Jean-Jacques; Lao, Christopher D; Márquez-Rodas, Iván; Wagstaff, John; Lebbé, Céleste; Pigozzo, Jacopo; Robert, Caroline; Ascierto, Paolo A; Atkinson, Victoria; Postow, Michael A; Atkins, Michael B; Sznol, Mario; Callahan, Margaret K; Topalian, Suzanne L; Sosman, Jeffrey A; Kotapati, Srividya; Thakkar, Pratik K; Ritchings, Corey; Pe Benito, Melanie; Re, Sandra; Soleymani, Samira; Hodi, F Stephen

MON-282 Referral Patterns and Perceptions of Interventional Radiologists in Adrenal Vein Sampling (AVS): A Survey of the American Association of Endocrine Surgeons

MON-282 肾上腺静脉取样(AVS)中介入放射科医生的转诊模式和认知:美国内分泌外科医师协会的一项调查

Chang, Lee-Shing; Barroso-Sousa, Romualdo; Tolaney, Sara M; Hodi, F Stephen; Kaiser, Ursula B; Min, Le; Neff, Marisela; Kozlowski, Konrad; Lin, Jack; Issa, Chloe; Patel, Anmol; Clode, Hannah; Pennix, Thomas; Vaghaiwalla, Tanaz; Lew, John I; Miller, Zoe

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047

RELATIVITY-047 研究分析了接受纳武利尤单抗单药治疗或联合瑞拉利单抗治疗的晚期黑色素瘤患者的无治疗生存期。

Regan, Meredith M; Ascierto, Paolo A MD; Lipson, Evan J; Palaia, Jennell; Moshyk, Andriy; Selvan, Abraham; Lao, Christopher D; Atkins, Michael B MD; McDermott, David F; Potluri, Ravi; Ranjan, Sandip; Bilthare, Sandeep; Long, Georgina V; Stephen Hodi, F; Tawbi, Hussein; Schadendorf, Dirk